Literature DB >> 17299378

Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.

A Onat1, G Can, G Hergenç, M Yazici, A Karabulut, S Albayrak.   

Abstract

OBJECTIVES: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.
METHODS: Prospective evaluation of 1125 men and 1223 women, aged 28-74 years, participating in the survey 1997/1998 who had serum apo B determinations and were followed-up for a mean 5.9 years. Tertiles of apo B were formed by cut points by 120 and 95 mg/dl. MS was defined by modified ATPIII criteria.
RESULTS: Apo B values exhibited no significant difference among sexes. Low-density lipoprotein (LDL)-cholesterol and triglycerides were their leading determinants on linear regression analysis. By logistic regression analyses, the top versus bottom apo B tertile predicted significantly newly developing MS in both sexes separately with two-fold relative risks (RRs) (P<0.02) and the development of high triglyceride/low high-density lipoprotein-cholesterol dyslipidemia with nearly threefold RRs (P=0.001), after adjustment for waist circumference, C-reactive protein (CRP), physical activity grade and family income category. Development of hypertension was predicted only in women by the apo B top tertile (fully adjusted RR 1.71 [95% CI 1.001; 2.92]), while the significance of the prediction regarding age-adjusted diabetes in women (RR 1.86 [95% CI 1.04; 3.36]) attenuated after adjustment for the stated confounding factors.
CONCLUSIONS: Apo B concentrations, which reflect the number of small, dense LDL particles in plasma, are a significant predictor of cardiometabolic risk among adults with a high prevalence of MS, independent of waist circumference and CRP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299378     DOI: 10.1038/sj.ijo.0803552

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  22 in total

1.  The Association of Polyunsaturated Fatty Acid δ-5-Desaturase Activity with Risk Factors for Type 2 Diabetes Is Dependent on Plasma ApoB-Lipoproteins in Overweight and Obese Adults.

Authors:  Valérie Lamantia; Simon Bissonnette; Viviane Provost; Marie Devaux; Yannick Cyr; Caroline Daneault; Christine Des Rosiers; May Faraj
Journal:  J Nutr       Date:  2019-01-01       Impact factor: 4.798

Review 2.  Pharmacological treatment and therapeutic perspectives of metabolic syndrome.

Authors:  Soo Lim; Robert H Eckel
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

3.  The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population.

Authors:  Li Zhong; Qifu Li; Yuanjuan Jiang; Dan Cheng; Zhoujun Liu; Bangqiong Wang; Rong Luo; Qingfeng Cheng; Hua Qing
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

4.  Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population.

Authors:  Sylvia H Ley; Stewart B Harris; Philip W Connelly; Mary Mamakeesick; Joel Gittelsohn; Thomas M Wolever; Robert A Hegele; Bernard Zinman; Anthony J Hanley
Journal:  Clin Chem       Date:  2010-01-28       Impact factor: 8.327

5.  Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis.

Authors:  X Wang; B Chen; N Lv; Q Liu; Aimin Dang
Journal:  Clin Rheumatol       Date:  2014-11-12       Impact factor: 2.980

6.  Associations between carotid artery wall thickness and cardiovascular risk factors using multidetector CT.

Authors:  L Saba; R Sanfilippo; R Montisci; G Mallarini
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

7.  Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.

Authors:  Filiz Guclu-Geyik; Altan Onat; Neslihan Coban; Evrim Komurcu-Bayrak; Vedat Sansoy; Günay Can; Nihan Erginel-Unaltuna
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

8.  High serum apolipoprotein E determines hypertriglyceridemic dyslipidemias, coronary disease and apoA-I dysfunctionality.

Authors:  Altan Onat; Günay Can; Ender Ornek; Erkan Ayhan; Nihan Erginel-Ünaltuna; Sani N Murat
Journal:  Lipids       Date:  2012-10-25       Impact factor: 1.880

Review 9.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

10.  Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.